Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.37
-0.04 (-0.43%)
At close: Nov 26, 2025, 4:00 PM EST
9.19
-0.18 (-1.92%)
After-hours: Nov 26, 2025, 4:16 PM EST
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $533.75 million as of November 26, 2025. Its market cap has increased by 42.61% in one year.
Market Cap
533.75M
Enterprise Value
329.52M
1-Year Change
42.61%
Ranking
Category
Stock Price
$9.37
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $533.75M, a decrease of -75.81%. That is a compound annual growth rate of -26.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 533.75M | 52.78% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 986.37B |
| Johnson & Johnson | 499.42B |
| AbbVie | 401.66B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 288.24B |
| Merck & Co. | 261.36B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 224.05B |